Bionano Genomics, Inc. Segments Disclosure
14. Segment Reporting
The following table presents financial information with respect to the Company’s operating segment, including significant segment expenses, which are regularly provided to the CODM and included within consolidated operating loss:
|
|
Year Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Revenues |
|
$ |
28,508,000 |
|
|
$ |
30,776,000 |
|
Cost of revenue |
|
|
15,323,000 |
|
|
|
30,396,000 |
|
Operating expenses |
|
|
|
|
|
|
||
Salaries, wages, and benefits |
|
|
24,353,000 |
|
|
|
51,136,000 |
|
Contracted services |
|
|
9,304,000 |
|
|
|
18,892,000 |
|
Non-inventory materials |
|
|
953,000 |
|
|
|
2,716,000 |
|
Consulting |
|
|
1,203,000 |
|
|
|
4,659,000 |
|
Rent and facilities |
|
|
2,553,000 |
|
|
|
4,095,000 |
|
Depreciation and amortization |
|
|
7,161,000 |
|
|
|
8,826,000 |
|
Travel and entertainment |
|
|
619,000 |
|
|
|
1,654,000 |
|
Administrative and other |
|
|
378,000 |
|
|
|
12,385,000 |
|
Total operating expenses |
|
|
46,524,000 |
|
|
|
104,363,000 |
|
Loss from operations |
|
$ |
(33,339,000 |
) |
|
$ |
(103,983,000 |
) |
Administrative and other primarily includes operating expenses for gain on lease termination/modification, intangible assets and other long-lived assets impairment, changes in fair value of contingent consideration, disposals of property, plant, and equipment, and taxes, interest, and fees.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 23, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.